Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients.

Stecker EC, Zargarian M, Dogra V, John BT, Kron J, McAnulty JH, Chugh SS.

Europace. 2006 Oct;8(10):859-62. Epub 2006 Aug 18.

PMID:
16920764
2.

Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.

Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.

Europace. 2006 Aug;8(8):618-24.

PMID:
16864615
3.

Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.

Borleffs CJ, Scherptong RW, Man SC, van Welsenes GH, Bax JJ, van Erven L, Swenne CA, Schalij MJ.

Circ Arrhythm Electrophysiol. 2009 Oct;2(5):548-54. doi: 10.1161/CIRCEP.109.859108. Epub 2009 Aug 5.

PMID:
19843923
4.

Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.

Korhonen P, Husa T, Tierala I, Väänänen H, Mäkijärvi M, Katila T, Toivonen L.

J Cardiovasc Electrophysiol. 2006 Apr;17(4):396-401.

PMID:
16643362
5.

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.

Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.

Eur Heart J. 2007 Jul;28(14):1746-9. Epub 2007 Feb 5.

PMID:
17283003
6.

Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.

Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.

Am J Cardiol. 2007 Aug 15;100(4):598-604. Epub 2007 Jun 28.

PMID:
17697813
7.

Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.

Duray GZ, Schmitt J, Richter S, Israel CW, Hohnloser SH.

Europace. 2009 Nov;11(11):1462-8. doi: 10.1093/europace/eup246. Epub 2009 Sep 29.

PMID:
19797255
8.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

9.

Fragmented QRS and mortality risk in patients with left ventricular dysfunction.

Cheema A, Khalid A, Wimmer A, Bartone C, Chow T, Spertus JA, Chan PS.

Circ Arrhythm Electrophysiol. 2010 Aug;3(4):339-44. doi: 10.1161/CIRCEP.110.940478. Epub 2010 May 28.

PMID:
20511537
10.

Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.

Lemola K, Khan R, Nattel S, Talajic M, Roy D, Guerra PG, Lemola S, Dubuc M, Thibault B, Macle L, Khairy P.

Pacing Clin Electrophysiol. 2009 Jan;32(1):99-105. doi: 10.1111/j.1540-8159.2009.02182.x.

PMID:
19140919
11.

ECG quantification of myocardial scar does not differ between primary and secondary prevention ICD recipients with ischemic heart disease.

Kraaier K, van Dessel PF, van der Palen J, Wilde AA, Scholten MF.

Pacing Clin Electrophysiol. 2010 Feb;33(2):192-7. doi: 10.1111/j.1540-8159.2009.02611.x. Epub 2009 Nov 4.

PMID:
19889190
12.

Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.

Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C.

Int Heart J. 2006 Sep;47(5):763-73.

13.

Survival in octogenarians receiving implantable defibrillators.

Koplan BA, Epstein LM, Albert CM, Stevenson WG.

Am Heart J. 2006 Oct;152(4):714-9.

PMID:
16996846
14.
15.

Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.

Spencker S, Coban N, Koch L, Schirdewan A, Müller D.

Europace. 2009 Apr;11(4):483-8. doi: 10.1093/europace/eun350. Epub 2008 Dec 22.

PMID:
19103654
16.

Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.

Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.

Europace. 2008 Mar;10(3):358-63. doi: 10.1093/europace/eun019.

PMID:
18308756
17.

Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).

Borleffs CJ, van Erven L, Schotman M, Boersma E, Kiès P, van der Burg AE, Zeppenfeld K, Bootsma M, van der Wall EE, Bax JJ, Schalij MJ.

Eur Heart J. 2009 Jul;30(13):1621-6. doi: 10.1093/eurheartj/ehp234. Epub 2009 Jun 2.

PMID:
19493865
18.
19.

Automated Quantification of Low-Amplitude Abnormal QRS Peaks From High-Resolution ECG Recordings Predicts Arrhythmic Events in Patients With Cardiomyopathy.

Das M, Suszko AM, Nayyar S, Viswanathan K, Spears DA, Tomlinson G, Pinter A, Crystal E, Dalvi R, Krishnan S, Chauhan VS.

Circ Arrhythm Electrophysiol. 2017 Jul;10(7). pii: e004874. doi: 10.1161/CIRCEP.116.004874.

PMID:
28705874
20.

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.

Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A; DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators.

Europace. 2008 May;10(5):528-35. doi: 10.1093/europace/eun072. Epub 2008 Apr 7.

PMID:
18390985

Supplemental Content

Support Center